Medline - Class A opened lower at $31.93, compared with its previous close of $32.00. In the last trading session, the stock traded between $31.37 and $32.23. It showed a sideways intraday trend.
An investment of $100 made 1 year ago in Medline - Class A is now worth
$ 78.03
resulting in a loss of
$ 21.97 (21.97%)
Note: Past profits do not guarantee future returns.
Rating from 20 Analysts
Today's Change
$-0.01 (-0.03%)
Day High
$32.23
Day Low
$31.37
Day Open
$31.93
Prev Close
$32.00
Volume
74,30,016
1W Return
-8.26%
1M Return
-8.50%
3M Return
-20.21%
6M Return
-26.29%
1Y Return
-21.97%
Market Cap ($ Mn)
28,068
PE Ratio
89.05
PB Ratio
2.67
PEG Ratio
-
ROE
16.98%
ROCE
5.98%
EPS (TTM)
-
1 Week
-8.26%
1 Month
-8.50%
3 Months
-20.21%
6 Months
-26.29%
9 Months
-26.84%
Medline exits brand beds with up to $220M cost, no guidance impact
Medline Inc announced the removal and market exit of all Medline brand beds. Estimated costs for the exit are up to $220 million. Company states no material impact on FY2026 guidance.
8 days agoBFA Law reiterates Medline probe after FDA warnings and stock drop
BFA Law reiterated its investigation into Medline Inc. for potential securities fraud on October 19, 2026. The probe follows FDA CGMP violations cited in May 2026 and a subsequent 12.79% stock drop in August 2026. Five law firms are currently examining Medline's disclosures regarding manufacturing quality and earnings guidance.
11 days agoMedline plans 800,000 sq ft Michigan distribution center
Medline Inc. will build an 800,000-square-foot distribution center in Van Buren Township, Michigan. The facility is scheduled to begin serving customers in late 2028. Ashley Capital is developing the site at Crossroads Distribution Center North. The investment aims to enhance supply chain resilience and capacity in the Midwest.
14 days agoFDA flags Medline kits for contamination from recalled BD products
FDA warns healthcare providers about Medline convenience kits containing recalled Becton Dickinson applicators due to packaging defects and fungal contamination risks. Medline advises immediate quarantine and removal of affected components, with zero severe injuries reported as of August 3.
2mo agoKaplan Fox investigates Medline Inc. after FDA warning letter
Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. for potential securities violations after an FDA warning letter highlighted manufacturing quality failures. Medline's stock price dropped 7.16% on June 2, 2026, following the news. The law firm is assessing whether the company adequately disclosed these regulatory issues to investors.
3mo agoMedline signs Prime Vendor agreement with Allina Health
Medline (NASDAQ: MDLN) signed a Prime Vendor agreement with Allina Health to provide medical-surgical products and supply chain solutions. The partnership covers Allina's 12 hospital campuses and over 90 clinics, aiming to optimize supply chain efficiency and product availability. Executives from both organizations emphasized the agreement's role in strengthening supply reliability and supporting care delivery.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $104.57 | +1.88% | $1,80,946.15M | 36.28 | |
| $448.76 | +1.03% | $1,55,559.96M | 42.73 | |
| $97.11 | +2.46% | $1,24,220.20M | 24.46 | |
| $311.75 | +2.55% | $1,19,578.88M | 34.27 | |
| $42.69 | +0.61% | $61,867.63M | 18.96 | |
| $94.44 | +2.90% | $54,435.22M | 53.70 | |
| $198.34 | +1.63% | $54,025.24M | 44.07 | |
| $252.83 | +1.06% | $35,557.76M | 23.04 | |
| $76.42 | +0.79% | $34,552.39M | 16.49 | |
| $71.13 | +1.86% | $34,384.24M | 54.55 | |
| $79.93 | +1.67% | $30,162.46M | 36.04 | |
| $416.67 | +3.23% | $29,323.57M | 43.21 |
An investment of $100 made 1 year ago in Medline - Class A is now worth
$ 78.03
resulting in a loss of
$ 21.97 (21.97%)
Note: Past profits do not guarantee future returns.
